Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Esperion Theraptc (ESPR)

55.3109 -1.819 (-3.18%)

12-12 12:45

Open:

57.49

Pre. Close:

57.13

High:

57.49

Low:

55.3109

Volume:

152,727

Market Cap:

1449M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

59.32 - 60.08

60.08 - 60.96

Low:

53.19 - 54.29

54.29 - 55.55

Close:

55.04 - 56.54

56.54 - 58.26

Technical analysis  (as of: 2017-12-12 11:22:44 AM)

Overall:

      

Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 76.15     One year: 88.95

Support:

Support1: 51.55    Support2: 43.12

Resistance:

Resistance1: 65.20    Resistance2: 76.15

Pivot:

57.91

Moving Averages:

MA(5): 55.85     MA(20): 55.73

MA(100): 50.33     MA(250): 38.29

MACD:

MACD(12,26): 1.93     Signal(12,26,9): 2.25

%K %D:

%K(14,3): 46.59     %D(3): 45.54

RSI:

RSI(14): 55.93

52-Week:

High: 65.2  Low: 10.71  Change(%): 366.6

Average Vol(K):

3-Month: 49381  10-Days 58721

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
ESPR has closed above bottom band by 44.6%. Bollinger Bands are 10.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 12 Dec 2017 04:41:15 GMT
Analysts Set Esperion Therapeutics, Inc. (ESPR) Target Price at $61.92

Tue, 08 Aug 2017 16:41:15 GMT
Here's What's Pushing Up Esperion Therapeutics Inc. Today

Fri, 22 Sep 2017 00:35:57 GMT
Esperion Therapeutics Remains Undervalued

Tue, 12 Dec 2017 17:15:00 GMT
Esperion Therapeutics, Inc. (ESPR) Reaches $56.18 After 9.00% Down Move ...

Mon, 11 Dec 2017 21:56:15 GMT
What's Unfolding For Shares of Esperion Therapeutics, Inc. (NasdaqGM:ESPR)

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

26.20

Shares Float (M)

19.61

% Held by Insiders

2.77

% Held by Institutions

108.96

Shares Short (K)

3900

Shares Short Prior Month (K)

4110

Stock Financials

EPS

-6.870

EPS Est. Current Year

-7.290

EPS Est. Next Year

-5.590

EPS Est. Next Quarter

-1.790

Forward EPS

-5.629

Book Value (p.s.)

10.620

PEG Ratio

-4.42

Profit Margin

Operating Margin

Return on Assets (ttm)

-34.6

Return on Equity (ttm)

-59.4

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-6.081

Qtrly Earnings Growth

Operating Cash Flow (M)

-112.74

Levered Free Cash Flow (M)

-55.11

atoplab.com

Valuation

P/E

-8.35

P/E Growth Ratio

P/BV

5.40

P/S

P/CF

-13.33

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.